<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00731458</url>
  </required_header>
  <id_info>
    <org_study_id>15606B</org_study_id>
    <nct_id>NCT00731458</nct_id>
  </id_info>
  <brief_title>Prospective Comparison of Cirrus Versus Stratus Ocular Coherence Tomography for Different Retinal Pathology.</brief_title>
  <official_title>Prospective Comparison of Cirrus and Stratus Optical Coherence Tomography for Quantifying Retinal Thickness</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Research to Prevent Blindness</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ocular Coherence Tomography (OCT) is a non-invasive ophthalmologic test that uses reflected,
      unheated, non-concentrated visible light in order to scan and provide a 2-dimensional
      topographic analysis of the retina and optic nerve. It has wide diagnostic utility especially
      in patients with clinically significant macular edema, glaucoma, and other retinal eye
      diseases. At the University of Chicago, we have utilized the Stratus brand OCT (Carl Zeiss
      Inc) for the past 5 years. Recently we have acquired a beta version of the company's new
      model, the Cirrus HD-OCT (Carl Zeiss Inc.) which features improved resolution, shorter
      scanning time and a more user-friendly interface. The purpose of this study is to compare
      findings between the two models in patients with different common and uncommon eye diseases,
      including diabetic macular edema, glaucoma and age-related macular degeneration. We
      hypothesis that the Cirrus OCT is able to accurately quantify eye pathology compared to
      Stratus OCT.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">November 2007</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <enrollment type="Actual">60</enrollment>
  <condition>Retinal Pathology</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical coherance tomography ( Cirrus; Stratus)</intervention_name>
    <description>Non-contact retinal thickness analyzer</description>
    <other_name>OCT; Cirrus; Stratus</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any eye pathology that may cause macular edema.

        Exclusion Criteria:

          -  Vitreous media opacities including dense cataracts, vitreous hemorrhage, and corneal
             opacities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seenu Hariprasad, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chicago</affiliation>
  </overall_official>
  <reference>
    <citation>Forooghian F, Cukras C, Meyerle CB, Chew EY, Wong WT. Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4290-6. doi: 10.1167/iovs.08-2113. Epub 2008 May 30.</citation>
    <PMID>18515567</PMID>
  </reference>
  <reference>
    <citation>Gupta V, Gupta P, Singh R, Dogra MR, Gupta A. Spectral-domain Cirrus high-definition optical coherence tomography is better than time-domain Stratus optical coherence tomography for evaluation of macular pathologic features in uveitis. Am J Ophthalmol. 2008 Jun;145(6):1018-1022. doi: 10.1016/j.ajo.2008.01.021. Epub 2008 Mar 17.</citation>
    <PMID>18343349</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 6, 2008</study_first_submitted>
  <study_first_submitted_qc>August 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2008</study_first_posted>
  <last_update_submitted>September 4, 2013</last_update_submitted>
  <last_update_submitted_qc>September 4, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 5, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>OCT;</keyword>
  <keyword>Cirrus;</keyword>
  <keyword>Stratus;</keyword>
  <keyword>macular thickness</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

